1623289 SMD standardized mean difference 12845 1623295 SMD steered molecular dynamics 374 1624453 SMD skeletal muscle density 221 1623353 SMD severe mental disorders 126 1624313 SMD standardized MD 104 1624327 SMD standard mean deviation 70 1624463 SMD single-molecule detection 55 1624384 SMD solvation model based on density 48 1624317 SMD stable metabolic disease 43 1623330 SMD severe mood dysregulation 36 1624263 SMD sternomental distance 32 1623380 SMD serous macular detachment 31 1623401 SMD sensory modulation disorder 29 1624211 SMD subjective memory decline 28 1623298 SMD steered MD 27 1623603 SMD Sauter mean diameter 23 1623764 SMD significantly improved pruritus 21 1624350 SMD spondylometaphyseal dysplasia 20 1624512 SMD surface mount device 20 1623397 SMD senile macular degeneration 19 1624372 SMD solvation model density 19 1624312 SMD standardized difference in means 19 1623518 SMD Stanford Microarray Database 18 1624261 SMD sterility mosaic disease 18 1624177 SMD sulfamethoxydiazine 18 1623544 SMD Social Media Disorder 17 1623563 SMD Skeletal muscle dysfunction 13 1624283 SMD statistical molecular design 13 1624275 SMD steered molecular dynamics simulations 13 1623385 SMD serious mental disorders 12 1624320 SMD standard MD 12 1623653 SMD single moving dipole 11 1624388 SMD solvation model 11 1624360 SMD spectral modulation detection 11 1623633 SMD Stau1-mediated mRNA decay 11 1623520 SMD Staufen-mediated mRNA decay 11 1623346 SMD severe and multiple disadvantage 10 1623568 SMD Simo decoction 10 1623541 SMD Sodium methyldithiocarbamate 10 1624274 SMD stereotypic movement disorder 10 1624358 SMD space and motion discomfort 9 1623634 SMD STD Mean Difference 9 1623499 SMD submucosal diathermy 9 1623402 SMD sensory modulation dysfunction 8 1623589 SMD sepsis-induced myocardial dysfunction 8 1623586 SMD Shegan Mahuang Decoction 8 1624385 SMD solvation model based on solute electron density 8 1624361 SMD speech motor delay 8 1624334 SMD spinal metastatic disease 8 1623516 SMD Stargardt's macular dystrophy 8 1624536 SMD surface microdischarge 8 1623960 SMD significant decrease in malondialdehyde (MDA) levels 7 1624122 SMD supplementation significantly reduced CRP 7 1624523 SMD surrogate minimal depth 7 1624407 SMD sodium bicarbonate 6 1624155 SMD superoxide dismutase 6 1624472 SMD systemic meningococcal disease 6 1623400 SMD sensory modulation difficulties 5 1623382 SMD septic myocardial dysfunction 5 1624421 SMD small-molecule drug 5 1623545 SMD Social Media Disorder Scale 5 1624331 SMD standard difference in means 5 1623506 SMD sulfur microbial diet 5 1624482 SMD symptoms of depression 5 1624479 SMD syndrome 5 1623403 SMD semantic dementia 4 1623585 SMD Shashen-Maidong Decoction 4 1623795 SMD significantly higher in PC patients compared to controls 4 1623715 SMD significantly lower FMD 4 1623654 SMD simultaneous methanogenesis and denitrification 4 1623553 SMD Single-metal deposition 4 1624390 SMD soil moisture deficit 4 1624370 SMD solvent model 4 1624340 SMD sphingomyelinase D 4 1624306 SMD standardized mean 4 1624269 SMD stochastic meta-descent 4 1623502 SMD Sugarcane mosaic disease 4 1624156 SMD superoxide dismutase (SOD) 4 1623366 SMD serum HDL 3 1623325 SMD severe mental disabilities 3 1624100 SMD shorter mating duration 3 1624043 SMD showed significant improvement at 0-6 months 3 1623882 SMD significant decrease in MDA 3 1623759 SMD significant improvement in quadriceps strength 3 1623840 SMD significantly compared with the model controls 3 1623720 SMD significantly higher in AD compared to MCI 3 1623699 SMD significantly reduced MDA 3 1624398 SMD smart mobile devices 3 1623534 SMD spastic movement disorders 3 1624335 SMD spine BMD 3 1624339 SMD spliceosome-mediated decay 3 1623522 SMD Spring-Mass-Damper 3 1623507 SMD Steinert's myotonic dystrophy 3 1624260 SMD sterile medical devices 3 1624199 SMD subgingival mechanical debridement 3 1624192 SMD submandibular duct 3 1623431 SMD symptoms compared to healthy controls 3 1624471 SMD systemic metabolic disorder 3 1623478 SMD on-medication states 2 1623470 SMD salamide 2 1623452 SMD salmon milt DNA 2 1623456 SMD sample mean difference 2 1623444 SMD scales compared with the placebo use 2 1623428 SMD scores when compared to control groups 2 1623441 SMD seafloor marine debris 2 1623614 SMD secondary mitochondrial dysfunction 2 1623426 SMD sedentary behaviour intervention compared to control 2 1623418 SMD sedimentation rate 2 1623419 SMD sedimentation rate (ESR) 2 1623387 SMD self-identified personal problems 2 1623404 SMD semiclassical Moyal dynamics 2 1623381 SMD septic myocardial depression 2 1623375 SMD serum estradiol 2 1623370 SMD serum level of vitamin D compared to placebo group 2 1623367 SMD serum MDA 2 1623368 SMD serum N-terminal pro-B-type natriuretic peptide level 2 1623594 SMD severe meningococcal disease 2 1623579 SMD severe motor deficit 2 1623577 SMD shared decision-making 2 1623304 SMD shared medical decision-making 2 1624059 SMD showed a significant improvement in pliability 2 1624070 SMD showed greater empathy than unmarried individuals 2 1624041 SMD showed moderate effects 2 1624035 SMD showed no effect on pain measured using a scale 2 1624046 SMD showed significant improvement 2 1623588 SMD Siberian musk deer 2 1623948 SMD significant difference in favor of RES treatment 2 1623922 SMD significant difference in operation time 2 1623899 SMD significant improvement in corrected distance visual acuity 2 1623870 SMD significant improvements with IV iron for cancer-related anemia 2 1623809 SMD significantly higher in patients with more severe COVID-19 2 1623801 SMD significantly higher in people with VaD compared to healthy subjects 2 1623802 SMD significantly higher in the NTG group compared to controls 2 1623785 SMD significantly impaired in the hypertensive group 2 1623776 SMD significantly improved endurance exercise performance 2 1623780 SMD significantly improved global cognitive function 2 1623756 SMD significantly improved left ventricular ejection fraction 2 1623727 SMD significantly Lower than MED in the complication rate 2 1623682 SMD significantly reduced malondialdehyde levels 2 1623567 SMD SilhouetteMobile device 2 1623688 SMD silymarin+Mediterranean hypocaloric diets 2 1623662 SMD similar activities outside of a competitive environment 2 1623663 SMD similar days of controlled ovarian hyperstimulation (COH) 2 1623658 SMD similar improvement on CRP when compared to MIT 2 1623673 SMD simulated competition 2 1623674 SMD simulated microwave disinfection 2 1623656 SMD simvastatin did not significantly reduce DHEA levels 2 1623554 SMD single-molecule dataset 2 1624449 SMD size of pharmacotherapy comparisons favoured intervention over control 2 1624454 SMD skeletal muscle depletion 2 1624401 SMD skeletal muscle differentiation 2 1623565 SMD skin microdialysis 2 1623651 SMD SL carriers were compared 2 1623644 SMD SM density 2 1624440 SMD small effects compared to placebo in reducing pain 2 1623660 SMD small in magnitude 2 1624416 SMD small to moderate effects 2 1624423 SMD smaller degree of chest interference with their social activities 2 1623635 SMD SMDs of fasting insulin 2 1624395 SMD snowmelt date 2 1623539 SMD social media data 2 1623538 SMD Social Model of Disability 2 1624405 SMD sodium molybdate dihydrate 2 1623542 SMD sodium pyruvate 2 1623530 SMD somatization disorder 2 1624352 SMD spatial mode dispersion 2 1623536 SMD Specialist in Medicines Development 2 1624333 SMD spine-malleolar distance 2 1624343 SMD spontaneous movement disorders 2 1624344 SMD spontaneous preterm birth and full-term controls was not statistically significant 2 1624307 SMD standardized mean drug-placebo differences 2 1624300 SMD static matrix detachment 2 1623517 SMD statistical model of deformation 2 1623511 SMD stress-related mental disorders 2 1623498 SMD submerged marine debris 2 1624170 SMD substance misuse disorder 2 1624167 SMD suffering from diseases 2 1624182 SMD suicidal MDD patients compared to their non-suicidal counterparts 2 1624184 SMD sulfadimidine 2 1624152 SMD sum-modulus difference 2 1623296 SMD summary mean difference 2 1624157 SMD superoxide dismutase (SOD) activity 2 1624101 SMD supplementation significantly reduced C-reactive protein (CRP) 2 1624102 SMD supplementation significantly reduced fasting glucose 2 1624537 SMD support their effect on medication adherence within one-month post-intervention 2 1624538 SMD supportive mobility device 2 1624149 SMD surface microvessel density 2 1623485 SMD swine manure digestate 2 1623486 SMD Symbol Coding Test 2 1624474 SMD symptoms of maternal depression 2 1624476 SMD symptoms score at the end of treatment 2 1623639 SMD Also, meta-analysis did not demonstrate any difference in grip strength 1 1623638 SMD ASM medial detachment 1 1623482 SMD back-specific function immediately after treatment 1 1623483 SMD diabetes mellitus (DM) compared to those with diabetes 1 1623484 SMD enlargement-skeletal muscle density 1 1623494 SMD exercises (MBE) demonstrated favorable effects for pain relief 1 1623495 SMD life-style modifications 1 1623496 SMD lipid-soluble vitamins: vitamin A 1 1623488 SMD magnesium-supplementation group had a significantly greater reduction in both SBP 1 1623489 SMD medication score 1 1623490 SMD methods-steered molecular dynamics 1 1623491 SMD middle-to-late-stage PD 1 1623492 SMD moderate superiority of anxiety alleviation 1 1623493 SMD moderate, statistically significant effect size 1 1623468 SMD moderate-sized beneficial effects on preventing mental health conditions 1 1623469 SMD mood state 1 1623640 SMD MS (MwMS) demonstrating reduced International Index of Erectile Function scores 1 1623473 SMD muscle strength around the ankle 1 1623474 SMD non-significant increase in endometrial thickness 1 1623475 SMD non-significant, reductions in uterine volume 1 1623476 SMD non-suicidal MDD patients 1 1623477 SMD non-syndrome controls 1 1623479 SMD results, mean differences 1 1623647 SMD S-ESPB compared to caudal block 1 1623601 SMD Sabah Museum Department 1 1623480 SMD saffron milk desserts 1 1623471 SMD saleable meat in the higher priced cuts 1 1623472 SMD salivary cortisol compared to controls 1 1623602 SMD Salvia miltiorrhiza derivative 1 1623453 SMD same conditions 1 1623454 SMD same effect was not noted in peri-implantitis 1 1623455 SMD same time, PA training prominently improved executive function 1 1623457 SMD samples compared with non-infected groups 1 1623458 SMD samples had significantly increased TNF-alpha 1 1623448 SMD sarcomas with myogenic differentiation 1 1623449 SMD sarcopenia in our older patient cohort; a CT density metric 1 1623450 SMD satisfaction: mindfulness 1 1623451 SMD sativus reduced insomnia severity 1 1623604 SMD Scale (HAMD) 1 1623605 SMD Scale (MDS-UPDRS) III 1 1623464 SMD scale as compared to placebo are bupropion 1 1623618 SMD Scaphometacarpal distance 1 1623465 SMD scar compared to TAC combined with cryotherapy 1 1623466 SMD schizophrenia compared with controls 1 1623467 SMD scholastic achievement was noted in low 1 1623616 SMD School of Medicine & Dentistry 1 1623617 SMD School-based interventions modestly reduced screen time 1 1623459 SMD sclerogenic macular degeneration 1 1623460 SMD sclerosis (MS) related tremor 1 1623461 SMD score (Mean difference (MD): -0.03, P=0.79), opioid consumption 1 1623462 SMD score compared to placebo 1 1623463 SMD score for the vitamin D intervention group 1 1623433 SMD score was found for total hip replacement compared with hemiarthroplasty 1 1623434 SMD score, antioxidants improved pain tolerance in chronic pancreatitis patients 1 1623609 SMD Score-Matching by Denoising 1 1623435 SMD score; (II) compared with pharmacotherapy, MSA 1 1623436 SMD scores also improved with EM 1 1623427 SMD scores between ketamine and ECT groups 1 1623437 SMD scores between PTSD patients and trauma-exposed controls 1 1623429 SMD scores compared to control intervention 1 1623430 SMD scores compared to extracorporeal shock wave therapy (ESWT) 1 1623432 SMD scores compared with selective serotonin reuptake inhibitors (SSRI) treatment alone 1 1623445 SMD scores did not show improvement 1 1623446 SMD scores in treatment-resistant depression 1 1623447 SMD scores were lower in the gum-chewing group during the active 1 1623438 SMD scores, combined therapies were more efficacious than WM 1 1623439 SMD scotoma mean depth 1 1623610 SMD Screening for metabolic disorders 1 1623440 SMD screw placement had fewer radiation dose than FG group 1 1623648 SMD SCS implantation with significant gains observed in pooled exercise capacity 1 1623442 SMD second measured dose 1 1623443 SMD second molar distal 1 1623611 SMD Secondary Manufacturing Department 1 1623413 SMD secondary mechanically disrupted 1 1623612 SMD Secondary Medical Districts 1 1623414 SMD secondary metastatic disease 1 1623415 SMD secondary methylation index 1 1623613 SMD Secondary mitochondrial disease 1 1623406 SMD secondary movement disorders 1 1623407 SMD secondary outcomes of efficacy at follow-up 1 1623408 SMD secondary outcomes, the effect on the child's anxiety 1 1623409 SMD secondary outcomes, there was a statistically significant improvement in CCT 1 1623410 SMD secondary progressive MS patients and controls 1 1623411 SMD sedation in reducing the dental anxiety among children 1 1623412 SMD sedation time 1 1623425 SMD sedative requirements 1 1623424 SMD sedentary elderly adults compared with controls 1 1623416 SMD sedentary men oxidized less fat than women 1 1623417 SMD sediments 1 1623420 SMD seed maturity date 1 1623421 SMD seeking medical attention 1 1623422 SMD seemed more effective 1 1623423 SMD segmentation methods 1 1623396 SMD self-administered forms of CBT had larger effect sizes 1 1623394 SMD self-assessments. eHealth-based guided self-help significantly reduced binge eating psychopathology 1 1623395 SMD self-care interventions improved QOL 1 1623386 SMD self-examination education significantly influences health beliefs in adult men 1 1623388 SMD self-management alone compared with usual care 1 1623389 SMD self-management domain of patient activation 1 1623390 SMD self-management program had fewer emergency department visits 1 1623391 SMD semaglutide 1 1623392 SMD semaglutide reduced liver stiffness 1 1623393 SMD semaglutide with metformin significantly reduced fasting blood glucose 1 1623405 SMD semipermeable membrane dressings 1 1623615 SMD Senile disciform macular degeneration 1 1623398 SMD sensor-based medical devices 1 1623399 SMD sensorimotor deficits 1 1623592 SMD Sensorimotor integration differences 1 1623383 SMD series (RMSSD) 1 1623384 SMD serious mental disorder diagnoses 1 1623362 SMD serous macular neuroretinal detachment 1 1623590 SMD Sertraline significantly increased mean arterial pressure 1 1623597 SMD Serum adiponectin levels were not associated with AAA diagnosis 1 1623363 SMD serum B-type natriuretic peptide 1 1623364 SMD serum BDNF level compared to the non-cognitive impairment group 1 1623591 SMD Serum BDNF levels were significantly lower in patients with AD 1 1623360 SMD serum blood glucose 1 1623365 SMD serum CK level was reduced when participants received massage intervention 1 1623361 SMD serum concentrations of high-density lipoprotein cholesterol (HDL-C) 1 1623373 SMD serum copper levels compared to controls 1 1623374 SMD serum copper levels post-treatment compared to pre-HD 1 1623376 SMD serum fasting blood glucose (FBG) 1 1623377 SMD serum ferritin is strongly associated with PCOS 1 1623378 SMD serum folate values were associated with patients with severe COVID-19 1 1623379 SMD serum hepcidin did not differ significantly between study groups 1 1623595 SMD Serum IL-6 decreased significantly in patients from the Europe subgroup 1 1623369 SMD serum indirect bilirubin and PD patients 1 1623598 SMD Serum lactate was higher in the postoperative death group 1 1623371 SMD serum levels of total antioxidant capacity (TAC) 1 1623372 SMD serum levels relative to those who responded well 1 1623347 SMD serum lipocalin-2 concentrations and psoriasis/PsA in overall population 1 1623596 SMD Serum RANKL-related factor osteoprotegerin (OPG) levels 1 1623348 SMD serum total antioxidant capacity (TAC) 1 1623349 SMD serum triglyceride 1 1623350 SMD serum uric acid levels 1 1623351 SMD serum vasoactive intestinal peptide (VIP) levels 1 1623359 SMD serum VEGF levels were significantly higher in DR patients 1 1623352 SMD serum vitamin D level decreased more in the progressive patients 1 1623343 SMD serum/plasma in subjects with high risk of cardiovascular diseases 1 1623593 SMD Set meal design 1 1623344 SMD severe and mild asthma was observed in Caucasians 1 1623345 SMD severe and mild to moderate asthmatics 1 1623354 SMD severe asthmatics the lung function difference was significant 1 1623355 SMD severe dementia 1 1623356 SMD severe form of the disease displayed significantly elevated copeptin levels 1 1623357 SMD severe material deprivation 1 1623358 SMD severe meibomian gland dropout 1 1623578 SMD Severe melanocytic dysplasia 1 1623331 SMD severe mood dysregulation syndrome 1 1623324 SMD severe motor dysfunction 1 1623580 SMD Severe mucosal dysplasia 1 1623575 SMD Severely dysplastic melanocytic nevi 1 1623326 SMD severely mentally disabled 1 1623327 SMD severely multi-disabled 1 1623328 SMD severity compared with placebo 1 1623329 SMD severity of mastalgia compared to the placebo 1 1623340 SMD severity, based on the Hamilton Rating Scale for Depression (HRSD) 1 1623341 SMD sex and age-matched healthy controls 1 1623332 SMD sex hormone-binding globulin (SHBG) 1 1623342 SMD sex hormone-binding protein 1 1623333 SMD sexual and communication satisfaction sub-dimension of sexual life quality 1 1623334 SMD sexual media diet 1 1623335 SMD sexually experienced; we refer to this plasticity as 'shorter-mating-duration 1 1623336 SMD sham for the antidepressant effect 1 1623337 SMD sham in alleviating depressive symptoms 1 1623338 SMD sham tDCS 1 1623339 SMD sham tDCS in ameliorating negative symptoms in schizophrenia patients 1 1623311 SMD sham treatment in reducing pain 1 1623312 SMD sham, whereas tDCS outcomes were inconclusive 1 1623303 SMD shared decision-making process 1 1623576 SMD Shared Minimum Distance algorithm 1 1623305 SMD shared-making decision 1 1623587 SMD Shengmai formula decoction 1 1623306 SMD shifted from insignificant to significant 1 1623307 SMD shoes compared to barefoot with EC 1 1623308 SMD short (6-months) and long-term (>6-months) outcomes 1 1623309 SMD short to moderate duration 1 1623310 SMD short-term (immediately post-intervention) positive effects on relieving anxiety 1 1623321 SMD short-term and long-term efficacy for depression 1 1623322 SMD short-term effect at high dosage for VJ improvement 1 1623313 SMD short-term effects of prism adaptation on neglect outcomes 1 1623314 SMD short-term pain reduction 1 1623323 SMD short-term TCE could relieve pain 1 1623315 SMD short-term treatment include CRP 1 1623316 SMD short-term treatment, that is, 90-120days 1 1623317 SMD short-term, middle-term, and long-term assessments 1 1623318 SMD shortened fracture healing times 1 1623319 SMD shortened telomere length and diabetes mellitus 1 1623320 SMD shortened the healing time compared with ACB 1 1624098 SMD shortened wound healing time 1 1624099 SMD shorter length of stay were associated with MIP 1 1624091 SMD shorter mating duration behavior 1 1624092 SMD shorter operative time in the adrenalectomy subgroup 1 1624093 SMD shorter procedure time relative to the C-ESD group 1 1624094 SMD shorter procedure time than C-ESD 1 1624095 SMD shorter telomere length in IPF patients compared to controls 1 1624096 SMD shorter telomere length than normal-weight children 1 1624097 SMD shorter time for orientation to place as compared with sevoflurane 1 1624077 SMD shorter time to DKA resolution 1 1624078 SMD shorter time to extubation as compared with propofol 1 1624079 SMD shorter wound closure time 1 1624080 SMD shoulder disability compared with EMT 1 1624071 SMD shoulder in favor of the experimental group 1 1624072 SMD shoulder range of motion, especially the flexion 1 1624073 SMD show a difference in preeclamptic compared to normotensive women 1 1624074 SMD show no impact on body mass index 1 1624075 SMD show that increased maternal arginine concentrations were observed in IUGR 1 1624086 SMD showed a decreased procedural time 1 1624087 SMD showed a good cancer therapeutic effect; mouse weight 1 1624088 SMD showed a greater increase in muscle hypertrophy than RTNF 1 1624089 SMD showed a larger improvement in IKDC subjective scores than females 1 1624090 SMD showed a meaningful difference in pain assessment 1 1624081 SMD showed a minimal reduction of systolic blood pressure 1 1624082 SMD showed a moderate effect on patient-reported change 1 1624083 SMD showed a moderate pooled effect size 1 1624084 SMD showed a moderately significant positive effect 1 1624085 SMD showed a modest yet considerable decline 1 1624056 SMD showed a potential benefit for improving depression 1 1624057 SMD showed a pronounced difference in AM 1 1624058 SMD showed a remarkable decrease 1 1624060 SMD showed a significant improvement in scar height 1 1624052 SMD showed a significant increase in EF after walnut consumption 1 1624053 SMD showed a significant positive effect of vitamin C on EF 1 1624054 SMD showed a significant reduction in visfatin levels following metformin treatment 1 1624055 SMD showed a statistically significant benefit for MBSR 1 1624064 SMD showed an improvement of clinically rated tremor severity 1 1624065 SMD showed an increased risk of microaggression 1 1624067 SMD showed better effectiveness in general condition improvement 1 1624066 SMD showed better HRQoL compared to control 1 1624068 SMD showed clearly better lymph node detection 1 1624076 SMD showed EMLA had an insignificant difference with the control interventions 1 1624069 SMD showed favourable outcomes compared to placebos for immediate 1 1624061 SMD showed greater impact 1 1624062 SMD showed greater improvement relative to the low/uncertain adherence group 1 1624063 SMD showed impairments in local efficiency of resting-state functional whole-brain topology 1 1624036 SMD showed improved visual acuity 1 1624037 SMD showed improvement with adjunctive PDT 1 1624038 SMD showed lower levels of tumor markers, including Alpha-Fetoprotein (AFP) 1 1624039 SMD showed maintained decreases in depression 1 1624040 SMD showed moderate QoL benefit 1 1624042 SMD showed more favourable pain Likert scale than meloxicam 1 1624034 SMD showed more favourable pain VAS score than celecoxib 1 1624051 SMD showed no improvement in pain reduction 1 1624044 SMD showed no notable improvement in CLBP outcomes 1 1624045 SMD showed no significant treatment effect 1 1624047 SMD showed non-significant reductions in alcohol consumption 1 1624048 SMD showed numerically higher point estimates for concentration 1 1624049 SMD showed patients using multi-strain interventions 1 1624050 SMD showed significant effects of baseline cognition impairment 1 1624023 SMD showed significant improvement in sleep quality with music therapy 1 1624016 SMD showed significant improvements in knee flexion strength 1 1624017 SMD showed significant improvements in muscle mass 1 1624015 SMD showed significant improvements in SS-QOL 1 1624018 SMD showed significant improvements in visual analog score 1 1624019 SMD showed significantly greater benefits when performing the aerobic exercises performance 1 1624020 SMD showed significantly higher minimum mental state examination (MMSE) 1 1624033 SMD showed that antioxidant vitamins reduced arterial stiffness significantly 1 1624024 SMD showed that caffeine increased performance in specific team-sport skills 1 1624025 SMD showed that compared with placebo, carbohydrate+protein 1 1624026 SMD showed that dexrazoxane was more effective than beta-blockers 1 1624027 SMD showed that dietary nitrate had significant effects on time-to-peak power 1 1624028 SMD showed that donepezil could significantly improve the MMSE 1 1624029 SMD showed that exposure to nanoparticles significantly induced pulmonary fibrosis 1 1624030 SMD showed that family intervention was associated with fewer delirium days 1 1624011 SMD showed that green tea consumption did not significantly affect FBS 1 1624012 SMD showed that host-modulating therapy significantly increased bone formation 1 1624021 SMD showed that IPT had significant effects on improving social functioning 1 1624022 SMD showed that LIPUS significantly reduced the time to fracture union 1 1624013 SMD showed that low frequency (LF)-rTMS 1 1624005 SMD showed that mind-body exercise 1 1624014 SMD showed that miR-21-5p 1 1624031 SMD showed that NAC caused more changes in body mass index 1 1624006 SMD showed that neuromuscular training improved power 1 1624007 SMD showed that obesity treatment interventions 1 1624032 SMD showed that Paro had a moderate effect on medication use 1 1624008 SMD showed that patients with dementia had lower blood lycopene 1 1624009 SMD showed that pharmacological interventions were effective in improving EDS 1 1624010 SMD showed that probiotics increased the abundance of Bifidobacterium 1 1624003 SMD showed that protein intake among Malaysians exceeded the recommendation 1 1624004 SMD showed that providing detailed information to patients significantly reduced pain 1 1623995 SMD showed that taVNS was more effective than cTBS 1 1623996 SMD showed that the application of compression therapy improved pain 1 1623997 SMD showed that the control group exhibited more scapular anterior tilt 1 1623998 SMD showed that the improvement was only visible in hypoxemic patients 1 1623999 SMD showed that the levels of miR-152-3p 1 1624000 SMD showed the most significant reduction 1 1624001 SMD showing lower Female Sexual Function Index scores 1 1623649 SMD SIFT-based Minutia Descriptor 1 1624002 SMD signal magnitude difference 1 1623984 SMD signal magnitude difference time series 1 1623985 SMD signal-magnitude-decay 1 1623986 SMD signals, was demonstrated by delivering some surface-mount technology 1 1623581 SMD Significance was observed after removing two outlier trials 1 1623978 SMD significant advantages over MA in OKS 1 1623979 SMD significant association between initial HMGB-1 levels and 30-day mortality remained 1 1623980 SMD significant association between microbial modulation and diastolic blood pressure 1 1623981 SMD significant association between periodontitis and impaired OHRQoL 1 1623982 SMD significant associations were noted regarding augmentation index 1 1623983 SMD significant benefits for managing RBD 1 1623991 SMD significant change in AMH levels after COVID-19 vaccination 1 1623992 SMD significant change was found for the males 1 1623993 SMD significant changes after hemodialysis, with higher salivary flow rate 1 1623994 SMD significant changes were found in fine motor skills 1 1623987 SMD significant combined mean difference among the surgery group 1 1623988 SMD significant decrease in AMH levels after COVID-19 infection 1 1623990 SMD significant decrease in anxiety scores for those receiving these supplements 1 1623964 SMD significant decrease in aspartate aminotransferase (AST) 1 1623989 SMD significant decrease in EDE-Q score after TMS 1 1623965 SMD significant decrease in homeostasis model of assessment-estimated beta-cell function (HOMA-B) 1 1623966 SMD significant decrease in hormonal parameters, such as female testosterone 1 1623967 SMD significant decrease in male testosterone concertation 1 1623961 SMD significant decrease in plasma vWF:Ag levels following statin therapy 1 1623962 SMD significant decrease in serum/plasma leptin concentration following probiotic/synbiotic supplementation 1 1623963 SMD significant decrease in total sperm count 1 1623972 SMD significant decrease of circulating Lp(a) levels after treatment with pioglitazone 1 1623973 SMD significant decrease of intraoperative and postoperative opioid consumption 1 1623974 SMD significant decrease of sperm total count 1 1623975 SMD significant decrement 1 1623977 SMD significant difference between fenugreek with mefenamic acid 1 1623968 SMD significant difference between glioma and non-glioma groups 1 1623969 SMD significant difference between groups in terms of TSS level 1 1623976 SMD significant difference between LAM and placebo 1 1623970 SMD significant difference between multidisciplinary and conventional rehabilitation on functional capacity 1 1623971 SMD significant difference between the bleomycin group and the 5-FU group 1 1623943 SMD significant difference between the two groups for both procedural time 1 1623944 SMD significant difference between tramadol and comparators like placebo 1 1623945 SMD significant difference in CSAES+MF 1 1623947 SMD significant difference in duration of mechanical ventilation 1 1623949 SMD significant difference in knowledge and comprehension scores 1 1623941 SMD significant difference in mortality or hospital stay 1 1623942 SMD significant difference in pain immediately after therapy 1 1623952 SMD significant difference in postoperative opioid consumption 1 1623953 SMD significant difference in radiation time between RA and FG group 1 1623946 SMD significant difference in RE between O-arm and C-arm 1 1623954 SMD significant difference in telomerase activity 1 1623955 SMD significant difference in terms of alleviating loneliness 1 1623956 SMD significant difference in the duration of motor block 1 1623957 SMD significant difference in the improvement of patients' quality of life 1 1623958 SMD significant difference in the mean visfatin level of GCF 1 1623959 SMD significant difference in the number of MII oocytes 1 1623950 SMD significant difference in the proximal 1 1623951 SMD significant difference in tumor volume on the preoperative MRI 1 1623930 SMD significant difference of Hcy levels in females 1 1623923 SMD significant difference one month after NSPT in diabetic patients 1 1623924 SMD significant difference over Epley maneuver alone in DHI score 1 1623925 SMD significant difference was documented for total EAT 1 1623926 SMD significant difference was found between the treatment and control groups 1 1623927 SMD significant difference was found in multiple sclerosis-related fatigue 1 1623928 SMD significant difference was manifested in WST, RSST, and DOSS 1 1623929 SMD significant difference was observed in periodontal clinical attachment level values 1 1623939 SMD significant difference was observed in the microneedle radiofrequency treatment subgroup 1 1623921 SMD significant difference was observed in the SM 1 1623931 SMD significant differences between exercise programs and control regarding cognition 1 1623932 SMD significant differences between experimental and control groups concerning social skills 1 1623933 SMD significant differences between left and right extremity nerves 1 1623934 SMD significant differences between relapsing-remitting MS patients and controls 1 1623940 SMD significant differences between RLS and CLS in operative time 1 1623935 SMD significant differences existed in depressive symptoms 1 1623936 SMD significant differences in LA volume 1 1623937 SMD significant differences in patients who were resistant to clarithromycin 1 1623938 SMD significant differences in serum alanine aminotransferase (ALT) 1 1623918 SMD significant differences in terms of operative duration 1 1623919 SMD significant differences in the domains of emotionality 1 1623920 SMD significant differences in the domains of internalizing problems 1 1623911 SMD significant differences in the domains of psychometric intelligence 1 1623912 SMD significant differences in the improvement of depression 1 1623913 SMD significant differences in the mean change of TG 1 1623914 SMD significant differences under dominant model 1 1623915 SMD significant differences were observed between methods overall 1 1623916 SMD significant differences were observed in induction time 1 1623917 SMD significant differences were observed in pooled menstrual pain intensity 1 1623910 SMD significant differences were seen in serum FSH 1 1623902 SMD significant effect in increasing physical activity levels in community-dwelling adults 1 1623903 SMD significant effect of PE on PS with mid-term interventions 1 1623904 SMD significant effect on motor function compared with placebo 1 1623905 SMD significant effect than resistance and mindfulness exercise 1 1623906 SMD significant effects of local mud application on pain 1 1623907 SMD significant effects on immune function immediately 1 1623908 SMD significant effects were found in terms of changes in proteinuria 1 1623909 SMD significant effects were observed for mobility 1 1623894 SMD significant effects were observed on MDA 1 1623583 SMD Significant enhancements were observed in anxiety 1 1623892 SMD significant for IL-6 only in amniotic fluid 1 1623893 SMD significant higher APV in non-CAD group compared to CAD group 1 1623884 SMD significant higher percentage diameter stenosis 1 1623885 SMD significant immediate effect on pain intensity 1 1623886 SMD significant immediate positive effects on fatigue 1 1623887 SMD significant impact observed on the VMO/VL ratio 1 1623888 SMD significant impact of red meat intake on insulin sensitivity 1 1623890 SMD significant improvement in anxiety compared to the control group 1 1623891 SMD significant improvement in caregivers' anxiety levels in the multidisciplinary group 1 1623889 SMD significant improvement in FVC was detected 1 1623895 SMD significant improvement in quality of life was also noted 1 1623896 SMD significant improvement in the 6-minute walk distance 1 1623897 SMD significant improvement in the instrumental activities of daily living performance 1 1623898 SMD significant improvement in the post-interventional depression scale 1 1623900 SMD significant improvement of EF in diabetic subjects 1 1623901 SMD significant improvement was found for fear of falling 1 1623872 SMD significant improvements in best-corrected visual acuity (BCVA) 1 1623873 SMD significant improvements in either composite dynamic balance measures 1 1623871 SMD significant improvements in MDS-UPDRS I 1 1623874 SMD significant improvements in participants' knowledge 1 1623865 SMD significant improvements in periodontal plaque index 1 1623866 SMD significant improvements in psychological outcomes, including decreases in distress 1 1623584 SMD Significant improvements in sensation were observed in both flap 1 1623867 SMD significant improvements were observed in erectile function 1 1623868 SMD significant improvements were observed in pain 1 1623869 SMD significant improvements were observed in the reduction in body weight 1 1623880 SMD significant in low- and middle-income countries 1 1623881 SMD significant in maternal blood 1 1623883 SMD significant increase in body mass index (BMI) following TMS 1 1623875 SMD significant increases in inflammation immediately 1 1623876 SMD significant increment in endoscopic remission in IBD patients 1 1623877 SMD significant increment of clinical remission in patients with IBD 1 1623878 SMD significant intervention effect on motivation, compared with controls 1 1623879 SMD significant medium effect in improving grip strength 1 1623851 SMD significant moderate effect in reducing disability 1 1623852 SMD significant moderate positive effect of RT was found 1 1623853 SMD significant motif difference 1 1623854 SMD significant movement difficulties 1 1623582 SMD Significant Multi-Domain Impairment 1 1623855 SMD significant negative impact of the pandemic on female sexual function 1 1623856 SMD significant postprocedure decrease in median AET 1 1623849 SMD significant reduction in body mass index (BMI) 1 1623850 SMD significant reduction in fibrous plaque volume 1 1623847 SMD significant reduction in ICAM-1 was observed 1 1623859 SMD significant reduction in left ventricular mass 1 1623860 SMD significant reduction in the immediate exercise group 1 1623848 SMD significant reduction in VAS compared to placebo 1 1623861 SMD significant reduction of monthly headache days 1 1623566 SMD Significant reduction was observed for malondialdehyde (MDA) 1 1623862 SMD significant reductions in FMD for childhood cancers 1 1623863 SMD significant reductions in inflammatory markers including CRP 1 1623864 SMD significant reductions were observed across nonmalignant dermatological conditions 1 1623857 SMD significant reductions were observed in duration of mechanical ventilation 1 1623858 SMD significant treatment effect of FMT on depression 1 1623831 SMD significant under the random-effect model 1 1623832 SMD significant, they were timed up and go test 1 1623833 SMD significantly affect body fat mass 1 1623834 SMD significantly ameliorated the levels of alanine transaminase 1 1623836 SMD significantly associated with higher Short Physical Performance Battery (SPPB) scores 1 1623837 SMD significantly associated with improved level of postoperative sensation 1 1623829 SMD significantly associated with improved morning PEF 1 1623830 SMD significantly associated with improvement of the TDD 1 1623835 SMD significantly associated with TNF-alpha levels when compared with control 1 1623846 SMD significantly better than PELD and MIS-TLIF in relieving dysfunction 1 1623839 SMD significantly compared to exercise intervention 1 1623841 SMD significantly dampened reward responsiveness 1 1623842 SMD significantly decrease total procedure time 1 1623843 SMD significantly decreased analgesia consumption 1 1623844 SMD significantly decreased blood malondialdehyde levels 1 1623845 SMD significantly decreased bone union time 1 1623838 SMD significantly decreased compared with the SSRI treatment group 1 1623827 SMD significantly decreased estimated blood loss 1 1623828 SMD significantly decreased in LBD patients with excessive daytime sleepiness (EDS) 1 1623819 SMD significantly decreased isometric hip abduction 1 1623820 SMD significantly decreased serum irisin levels 1 1623821 SMD significantly decreased significantly serum levels of FPG 1 1623822 SMD significantly decreases MDA levels 1 1623823 SMD significantly decreases plasma TIMP-1 levels 1 1623824 SMD significantly demonstrated higher exam performance 1 1623825 SMD significantly different between two groups in the random-effects model 1 1623826 SMD significantly different from placebo 1 1623811 SMD significantly different in the duodenum 1 1623813 SMD significantly elevated albumin levels 1 1623814 SMD significantly elevated in the MCI patients, while Se 1 1623812 SMD significantly elevated NLR levels compared to survivors 1 1623815 SMD significantly enhanced in COPD patients compared with those in controls 1 1623816 SMD significantly extended the time until the first rescue analgesia 1 1623817 SMD significantly favorable effect on reducing pain for patients undergoing hemodialysis 1 1623818 SMD significantly greater pain reduction compared to conservative management 1 1623799 SMD significantly greater reductions in RS compared to fentanyl 1 1623796 SMD significantly higher absolute BMR/RMR during puberty 1 1623797 SMD significantly higher expression of BDNF levels as compared to controls 1 1623800 SMD significantly higher Hcy levels compared to counterparts without obesity 1 1623810 SMD significantly higher in diarrhea predominant IBS (IBS-D) compared to control 1 1623808 SMD significantly higher in patients with glaucoma compared to controls 1 1623803 SMD significantly higher in the letrozole group compared to CC group 1 1623798 SMD significantly higher LBP levels among MetS compared to non-MetS individuals 1 1623804 SMD significantly higher level of Lp(a) compared to the controls 1 1623805 SMD significantly higher levels of endocan compared to those without ARDS 1 1623806 SMD significantly higher performance for both medical 1 1623807 SMD significantly higher plasma levels of ET-1 compared to controls 1 1623788 SMD significantly higher than MIS-TLIF and PLIF in the recurrence rate 1 1623789 SMD significantly higher thickness compared to the control group 1 1623790 SMD significantly higher total BMD 1 1623781 SMD significantly higher value for the DMFT compared with tasters 1 1623782 SMD significantly higher, and vitamins A 1 1623783 SMD significantly impaired during AECOPD compared to recovery/stable condition 1 1623784 SMD significantly impaired endothelial function in patients versus controls 1 1623786 SMD significantly improve dynamic balance 1 1623787 SMD significantly improve dysphagia scores 1 1623793 SMD significantly improve the FMD compared to the control group 1 1623794 SMD significantly improved 6-minute walk distance 1 1623770 SMD significantly improved active range of motion (ROM) 1 1623771 SMD significantly improved after CRP compared to control 1 1623766 SMD significantly improved both total 1 1623767 SMD significantly improved by cut-out orthoses 1 1623768 SMD significantly improved children's compliance with anaesthesia 1 1623777 SMD significantly improved flow-mediated dilation (FMD) following acute 1 1623778 SMD significantly improved forward head posture 1 1623779 SMD significantly improved gait performance 1 1623772 SMD significantly improved global cognitive function compared to the control group 1 1623773 SMD significantly improved global cognitive function in stroke patients 1 1623774 SMD significantly improved glycaemic control 1 1623775 SMD significantly improved health-related QoL and disease-specific QoL 1 1623752 SMD significantly improved in the HBO group 1 1623753 SMD significantly improved key metabolic parameters: FBG 1 1623754 SMD significantly improved knowledge acquisition 1 1623755 SMD significantly improved learning on a transfer test 1 1623757 SMD significantly improved low-frequency hearing thresholds 1 1623758 SMD significantly improved mental health 1 1623749 SMD significantly improved mental health as assessed by quality of life 1 1623750 SMD significantly improved muscle strength in the knee extensors 1 1623751 SMD significantly improved neurobehavioral deficits 1 1623791 SMD significantly improved NMS, including depression 1 1623761 SMD significantly improved performance in the number connection test 1 1623762 SMD significantly improved performance on a post-acquisition test 1 1623763 SMD significantly improved perioperative subjective sleep quality 1 1623792 SMD significantly improved PFM contraction 1 1623765 SMD significantly improved pruritus compared with placebo 1 1623760 SMD significantly improved quality of life 1 1623744 SMD significantly improved the hemoglobin levels 1 1623769 SMD significantly improved VOmax compared with RT alone 1 1623745 SMD significantly improved with rPMS intervention 1 1623746 SMD significantly in the DR group compared with the control group 1 1623747 SMD significantly increased Clostridium 1 1623748 SMD significantly increased compared with healthy controls 1 1623743 SMD significantly increased core body temperature 1 1623736 SMD significantly increased in AITD patients when compared with healthy people 1 1623737 SMD significantly increased isometric peak torque via cross-education 1 1623738 SMD significantly increased quadriceps muscle strength 1 1623739 SMD significantly increased the abundance of Akkermansia 1 1623740 SMD significantly increased the volume 1 1623742 SMD significantly larger in lithium-treated bipolar patients compared to lithium-free patients 1 1623741 SMD significantly larger NC compared to non-PCOS controls 1 1623722 SMD significantly larger postintervention minimal luminal diameter 1 1623723 SMD significantly less intraoperative estimated blood loss in patients with hepatolithiasis 1 1623714 SMD significantly longer mean DTN compared to in-person evaluation 1 1623724 SMD significantly longer QT wave maximum duration 1 1623718 SMD significantly lower copper levels compared to HC 1 1623719 SMD significantly lower flow-mediated dilatation 1 1623716 SMD significantly lower FMD% values 1 1623721 SMD significantly lower in GDM compared to healthy controls 1 1623734 SMD significantly lower in glioma compared to meningioma 1 1623735 SMD significantly lower in individuals with CVDs compared to healthy controls 1 1623733 SMD significantly lower in the high adherence MD group 1 1623725 SMD significantly lower nNO values when compared to both healthy controls 1 1623726 SMD significantly lower post-operative drain volume 1 1623717 SMD significantly lower VF with high adherence to the Mediterranean diet 1 1623728 SMD significantly lowered after periodontitis treatment 1 1623729 SMD significantly more effective in improving the language comprehension developmental quotient 1 1623730 SMD significantly more effective than placebo in reducing both SS 1 1623731 SMD significantly more effective than radiofrequency treatment 1 1623732 SMD significantly more effects when compared to the control groups 1 1623703 SMD significantly positive effects on reducing pain intensity immediately 1 1623702 SMD significantly reduce anti-Mullerian hormone (AMH) 1 1623701 SMD significantly reduce HAMD scores 1 1623694 SMD significantly reduce pain among people with multiple sclerosis 1 1623695 SMD significantly reduce plasma D-dimer levels 1 1623696 SMD significantly reduce postoperative intubation time compared with routine hyperoxia 1 1623697 SMD significantly reduced 24-hour opioid consumption compared to control groups 1 1623711 SMD significantly reduced after AHSCT compared to the pretreatment period 1 1623712 SMD significantly reduced body weight compared with control diets 1 1623713 SMD significantly reduced both bone resorption, bone formation markers 1 1623704 SMD significantly reduced burnout in the immediate term 1 1623705 SMD significantly reduced cerebral infarct volume 1 1623706 SMD significantly reduced fluoroscopy time 1 1623707 SMD significantly reduced following GFAF treatment compared with no antidepressant treatment 1 1623708 SMD significantly reduced glucagon levels compared to other OADs 1 1623709 SMD significantly reduced in the ezetimibe/statin group 1 1623710 SMD significantly reduced knee pain compared with controls 1 1623698 SMD significantly reduced LFC compared to controls 1 1623700 SMD significantly reduced MDA levels 1 1623683 SMD significantly reduced muscle atrophy in quadriceps femoris muscle mass 1 1623684 SMD significantly reduced plasma BDNF levels in glioma patients versus controls 1 1623676 SMD significantly reduced postprandial glycemia 1 1623677 SMD significantly reduced postprandial plasma glucose levels compared to glucose 1 1623678 SMD significantly reduced the average fatigue compared to the control group 1 1623679 SMD significantly reduced the levels of inflammatory factors, including hs-CRP 1 1623680 SMD significantly reduced the number of anti-VEGF injections 1 1623681 SMD significantly reduced the rheumatoid factor (RF) level at the first 1 1623689 SMD significantly reduced with UGC compared to SA 1 1623690 SMD significantly reducing the probiotic genus Bifidobacterium 1 1623691 SMD significantly the RADIO assessments 1 1623692 SMD significantly up-regulated in PC groups compared with non-cancerous group 1 1623693 SMD significantly, in patients with hypothyroidism compared with healthy controls 1 1623650 SMD SIJ manual therapy did not significantly reduce pain 1 1623685 SMD silicone multilayered foam dressing 1 1623686 SMD silymarin combined with the medication 1 1623687 SMD silymarin significantly reduced levels of fasting blood glucose 1 1623664 SMD similar effectiveness as moderate-intensity endurance training 1 1623665 SMD similar effects to ABD alone for functional improvement 1 1623666 SMD similar for iCBT and usual treatment groups 1 1623667 SMD similar for surgically and non-surgically treated patients 1 1623659 SMD similar improvements with very low certainty of evidence in pain 1 1623661 SMD similar results in stable COPD patients 1 1623570 SMD Similar results were obtained with PI compared to H sites 1 1623571 SMD Similar, but less robust, results were observed with paroxetine 1 1623572 SMD Similarly, IL-17 levels were markedly higher in TED patients overall 1 1623573 SMD Similarly, NPDR 1 1623574 SMD Similarly, TEA was associated with shorter ICU stays 1 1623670 SMD simple deterministic 1 1623671 SMD simple monolithic discs 1 1623672 SMD simple straight hydrodynamic flow focusing 1 1623675 SMD simulated volleyball matches 1 1623668 SMD simulator had a greater effect on knowledge acquisition 1 1623669 SMD simultaneous determination 1 1623655 SMD simultaneous monocular detection 1 1623569 SMD Singapore Maritime Dataset 1 1623657 SMD single maximum duration 1 1623652 SMD single morning dosage 1 1624464 SMD single-molecule fluorescence detection 1 1624455 SMD single-port VATS lobectomy was associated with a longer operating time 1 1624456 SMD sinonasal mucosa disease 1 1624457 SMD sinus mucosa diseases 1 1624448 SMD sinus rhythm had a significantly lower volume of peri-LA EAT 1 1623555 SMD Sirius maximum density 1 1623556 SMD Site-Modulated Diffusion 1 1624450 SMD size-weighted mean difference 1 1624451 SMD sizes resulted in a greater improvement in IKDC subjective 1 1624452 SMD skeletal maturity deviation 1 1623552 SMD Skeletal muscle area and density 1 1624461 SMD skeletal muscle development 1 1624462 SMD skeletal muscle disorders 1 1623551 SMD Skeletal Muscle Dystrophy 1 1624458 SMD skeletal muscle index (SMI) 1 1624459 SMD skeletal muscle mass index 1 1624460 SMD skeletal-muscular disease 1 1623564 SMD Sketch-guided human Motion Diffusion 1 1624437 SMD skim milk-derived 1 1624438 SMD skin flap compared with the control group 1 1624429 SMD skin of patients as compared to the controls 1 1623641 SMD SLE patients compared to controls 1 1623642 SMD SLE patients had elevated urinary ICAM-1 1 1623643 SMD SLEDAI scores in patients suffering from SLE 1 1624430 SMD sleep apnea among opioid users 1 1624431 SMD sleep movement disorders 1 1624432 SMD sleep quality compared with placebo 1 1623557 SMD Slidex() MRSA detection kit 1 1623558 SMD Sliding Mode Differentiator 1 1623559 SMD Slope measuring deflectometry 1 1624433 SMD slow membrane depolarization 1 1624434 SMD slow-moving chromosomal DNA 1 1624435 SMD sludge disintegration phenomenon occurred with particle size reduction 1 1623645 SMD SM radiodensity 1 1624436 SMD small and statistically significant increase in total bilirubin 1 1624447 SMD small clinical effect in six studies 1 1624445 SMD small effect in the reduction of NSAIDs intake 1 1624446 SMD small effect on reducing overall anxiety 1 1624439 SMD small effect was found on the waist circumference 1 1624441 SMD small effects on reducing AST 1 1623560 SMD Small effects, were found for linear sprint 1 1624442 SMD small improvements in mental well-being compared with active controls 1 1624443 SMD small improvements in physical independence 1 1623561 SMD Small molecular weight dextran 1 1624444 SMD small molecule donor:polymer acceptor 1 1623562 SMD Small overall effects were observed for gait 1 1624419 SMD small reduction in pain intensity 1 1624411 SMD small reduction in the number of transferred embryos was observed 1 1624418 SMD small reduction in VAT 1 1624412 SMD small to large, while differences for early 1 1624413 SMD small to medium effect on alcohol consumption 1 1624414 SMD small to medium effect size improvement 1 1624415 SMD small to moderate deficits in three domains-learning, memory and intelligence 1 1624417 SMD small to moderate positive effects on endurance capacity 1 1623543 SMD Small vessel disease 1 1624426 SMD small, differences in depressive symptom scores than non-users 1 1624427 SMD small, non-significant effect in body composition changes 1 1624428 SMD small, significant effect in food-insecure settings on both LAZ 1 1624420 SMD small-molecule donors-a diketopyrrolopyrrole-based small molecule 1 1624422 SMD smaller benefits than very potent corticosteroids 1 1624424 SMD smaller drop in hemoglobin (Hb) level 1 1624425 SMD smaller minimal luminal diameter 1 1623646 SMD SMD $$ mathrm 1 1623626 SMD SMD and less heterogeneity 1 1623627 SMD SMD between adolescents and adults or elderly individuals 1 1623628 SMD SMD compared to exercise with low or uncertain ACSM adherence 1 1623629 SMD SMD default radii 1 1623619 SMD SMD of HDL-C 1 1623620 SMD SMD of HOMA-IR 1 1623621 SMD SMD of MBLs was moderate 1 1623622 SMD SMD revealed no significant differences in postoperative pain 1 1623623 SMD SMD-defined myosteatosis 1 1623624 SMD SMD: -0.91, 95% CI: -1.88-0.07, P 1 1623625 SMD SMD: 1.42, 95% CI: -4.49-7.33, P 1 1623636 SMD SMI patients and controls 1 1624399 SMD smoke maximum density 1 1624400 SMD smokers compared to non-smokers 1 1623637 SMD SMZL patients demonstrated diminished 5-year OSR 1 1624402 SMD snack consumption combined post-intervention 1 1624396 SMD social and material deprivation 1 1624397 SMD social communication deficits 1 1623540 SMD Social media dependence 1 1624406 SMD social media detox 1 1623537 SMD Social Media Disorder Short Form 1 1624408 SMD sodium bicarbonate combined with caffeine 1 1624409 SMD sodium bicarbonate did not preserve graft function 1 1624410 SMD sodium bicarbonate on proteinuria 1 1624403 SMD sodium bicarbonate when considering data from all included studies 1 1624404 SMD sodium content 1 1624389 SMD sodium-meglumine diatrizoate 1 1623550 SMD Soft Matter Dynamics 1 1624391 SMD soil moisture drydown 1 1623549 SMD Solanum metabolic database 1 1623546 SMD Solar Membrane Distillation 1 1624392 SMD solid diameter 1 1624393 SMD solid medium dilution 1 1624394 SMD solid microcrystalline dispersion 1 1624386 SMD solute molecule interacting with a continuum description of the solvent 1 1624387 SMD solution-mixed doping 1 1623547 SMD Solvation Method based on Density 1 1624373 SMD solvation models based on the quantum mechanical charge density 1 1623529 SMD Solvent effects are modeled via implicit 1 1623548 SMD Solvent Model D polarizable continuum model 1 1624371 SMD somatic depression 1 1624381 SMD somatic depression patients 1 1624382 SMD somatized mental disorder 1 1624383 SMD somatoform disorders 1 1624374 SMD somatoform disorders were not significant 1 1624375 SMD somatosensory dysregulation 1 1624376 SMD some extent HDL-C levels 1 1624377 SMD sorbent membrane dialysis 1 1623523 SMD Sorsby macular dystrophy 1 1624378 SMD sound disappearance time 1 1624379 SMD source-midline distance 1 1624380 SMD source-to-mid-sagittal-plane distance 1 1623524 SMD Souss Massa Draa 1 1623525 SMD Southern Metropolis Daily 1 1624357 SMD soy milk digestion extract 1 1623526 SMD Soybean mosaic disease 1 1623527 SMD SpA assessment, ASDAS-CRP 1 1623528 SMD Spartan Molecular Database 1 1624359 SMD spastic motor disorders 1 1624351 SMD spatial mapping device 1 1623535 SMD Spatial modulation diversity 1 1624353 SMD spatial multiplexing detection 1 1624354 SMD special medical detachments 1 1624355 SMD specialized medical degree 1 1624356 SMD species 5, 7, and 6, were calculated at M06-L-D3 1 1624369 SMD specific marker design 1 1624368 SMD specific QoR dimensions, with substantial effects on pain 1 1624367 SMD spectral mode depletion 1 1623531 SMD Speech Maturity Dataset 1 1624362 SMD speech motor disorders 1 1624363 SMD speech/music discrimination 1 1624364 SMD speed between admission and discharge 1 1624365 SMD speed monitoring display 1 1624366 SMD speed, greater lower-limb 1 1624342 SMD sperm DNA fragmentation 1 1623532 SMD Spherical Multi-Scale Dynamic 1 1624341 SMD sphingomyelinase deficiency 1 1624336 SMD spine bone mineral density (BMD) 1 1624337 SMD spine, femoral neck, and femoral trochanter and in postmenopausal women 1 1623533 SMD Spirometra Mansoni Dataset 1 1624338 SMD spleen and thymus, spleen index 1 1624349 SMD spondylo-metaphyseal chondrodysplasia 1 1624345 SMD sporadic MD 1 1624346 SMD sporadic Meniere's disease 1 1624347 SMD sport-specific actions during competition, such as the number of sprints 1 1624348 SMD springmass-damping 1 1624322 SMD sprint protocols in comparison with CHO isolated ingestion 1 1624323 SMD square mean diameter 1 1624324 SMD squared Mahalanobis distance 1 1623630 SMD SRF height was associated with better outcomes 1 1623631 SMD SSD compared to controls, while Quinolinic Acid 1 1623632 SMD SSNB led to considerable enhancements in abduction 1 1624325 SMD stable HR compared to fentanyl 1 1624318 SMD stage had significantly higher plasma fibrinogen level 1 1624319 SMD stand-alone Computerized interventions reduced short 1 1624321 SMD standard deviation in means 1 1624329 SMD standard deviation modified Ferriman-Gallway (MF-G scores) 1 1624330 SMD standard deviation of normal-to-normal intervals (SDNN) 1 1624332 SMD standard maintenance 1 1624326 SMD standard maintenance dosage 1 1624328 SMD standard mean difference in days 1 1624316 SMD standard mean square error 1 1624315 SMD standard moradol dose 1 1624314 SMD standard-dose psilocybin compared with control without considerable heterogeneity 1 1624310 SMD standardised difference in right and left means 1 1624308 SMD standardised mean difference adjusted for publication bias 1 1624309 SMD standardised mean different constraint threshold 1 1623521 SMD Standardized between-group mean difference 1 1624311 SMD standardized change in mean difference 1 1624303 SMD standardized mean difference effect size 1 1624304 SMD standardized mean difference within studies 1 1624305 SMD standardized mean difference, with versus without a tourniquet 1 1624289 SMD standing time 1 1623519 SMD Stargardt macular degeneration 1 1624290 SMD start minute digits 1 1624291 SMD state compared to the native state 1 1624302 SMD state was associated with greater changes in body fat mass 1 1624301 SMD static memory deduplication 1 1624292 SMD static mode degradation 1 1624293 SMD stating name as compared with propofol 1 1624294 SMD statins as a class were compared with placebo 1 1624295 SMD statins performed best at week eight 1 1624296 SMD statistical and medical data 1 1624297 SMD statistical difference, however, was found in glycosylated hemoglobin 1 1624298 SMD statistical differences for upper-limb 1 1624299 SMD statistical improvements were found in QOL 1 1624276 SMD statistically different effect on pain measured using a scale 1 1624277 SMD statistically significant across domains: mental health 1 1624278 SMD statistically significant correlation between infertility-related stress and IVF/ICSI outcomes 1 1624279 SMD statistically significant effects were discerned in terms of life satisfaction 1 1624280 SMD status associations, revealing that HPV-positive tumors consistently exhibited lower ADCmean 1 1624281 SMD status compared to SC 1 1624282 SMD status for reaction time, school attendance and scholastic achievement 1 1624287 SMD steatohepatitis (NASH) compared to controls 1 1624288 SMD steatosis (measured by ultrasound grading) 1 1624284 SMD steatosis and mild steatosis 1 1624285 SMD steatosis with a medium effect size 1 1624286 SMD steel mill dust 1 1623508 SMD Stent misdeployment 1 1624262 SMD sternomandibularis 1 1623607 SMD STH-related associations in all domains but intelligence 1 1623608 SMD STH-related deficits in learning, memory and reaction time tests 1 1624256 SMD stiffness and improve vascular endothelial function 1 1624257 SMD stimulated whole saliva (SWS) 1 1624258 SMD stimulation analgesia may provide a moderate improvement in function 1 1624259 SMD stimulation in reducing pain associated with PD 1 1624268 SMD stimulation location, right dorsolateral prefrontal cortex (DLPFC) 1 1624270 SMD stochastic mirror descent 1 1624271 SMD stoma adjustment 1 1624272 SMD stomatology medical doctor 1 1624273 SMD stone mineral density 1 1624264 SMD strategies to moderate drinking 1 1624265 SMD strategy improved the Wmean 1 1624266 SMD strategy markedly reduced the total treatment duration 1 1624267 SMD strategysteered molecular dynamics 1 1623509 SMD Street Medicine Detroit 1 1624241 SMD strength increase was observed in RTNF considering nonequalized volumes 1 1624242 SMD strength training improved the performance on dynamic balance testing 1 1624243 SMD strength was measured in a fatigued 1 1623510 SMD Strength, mobility and endurance revealed large overall effects 1 1624244 SMD strengthening is less effective than McKenzie exercises for pain reduction 1 1624245 SMD strengthening produced comparable effects for pain 1 1624235 SMD stress and apoptosis was the predominantly effective strategy 1 1624236 SMD stress induced a moderate 1 1624237 SMD stress reduction programs were effective on depression 1 1624238 SMD stress was also relieved by reducing malondialdehyde 1 1624239 SMD stress was also relieved, as evidenced by decreased malondialdehyde levels 1 1624240 SMD stress were detected immediately 1 1624253 SMD stress-induced mRNA decay 1 1624254 SMD stroke compared to nonstroke control groups 1 1624255 SMD stroke-associated pneumonia (SAP) 1 1624246 SMD strongest effect on treatment-related motor complications 1 1624247 SMD strongest relating to medium vs low doses 1 1624248 SMD strongly associated than BMI 1 1624249 SMD structural material degradation 1 1623512 SMD Structurally Missing Data 1 1623606 SMD STS plus WM reduced plasma viscosity 1 1623599 SMD STS plus WM reduced the incidence of adverse events 1 1623600 SMD STSFc ablation tended to have shorter fluoroscopic times 1 1624250 SMD studied using approximation IEFPCM 1 1624251 SMD studies assessing quality of life outcomes 1 1624252 SMD studies confirmed this finding 1 1624221 SMD studies demonstrated a significant reduction in DeMeester score 1 1624222 SMD studies demonstrated increased musculoskeletal function at 3-6months 1 1624223 SMD studies failed to show a statistically significant benefit for MBSR 1 1624213 SMD studies from Asia 1 1624214 SMD studies from developed countries had a larger effect size 1 1624215 SMD studies from developing countries 1 1624216 SMD studies from the western countries 1 1624217 SMD studies indicated a nonsignificant effect on VCAM-1 1 1624218 SMD studies indicated an effect on improving self-efficacy 1 1624219 SMD studies indicated the significant effect of Orlistat on waist circumference 1 1624220 SMD studies of NGAL measured at the first 1 1624233 SMD studies recruiting predominantly preschool children 1 1624234 SMD studies that included patients with multiple psychiatric diagnoses 1 1624232 SMD studies that recruited different types of MS (Mix) 1 1624224 SMD studies was accompanied by a large confidence interval 1 1624225 SMD studies with a multiple-use design 1 1624226 SMD studies with mixed ATS use frequency 1 1624227 SMD studies with unadjusted estimates 1 1624228 SMD studies, analysis revealed obvious IOP reduction after XEN stent implantation 1 1624229 SMD studies, nicorandil therapy increases cardiac pump function 1 1624230 SMD study had a large measure of effect in total 1 1624231 SMD study in the experimental group compared to the control group 1 1624203 SMD study medication discontinuation 1 1624202 SMD study, compared to DF 1 1624194 SMD sub-dimension of sexual life quality 1 1624195 SMD sub-domains, RE, compared to NEX, improved inhibitory control 1 1624196 SMD subclinical atherosclerosis as determined by carotid intima-media thickness 1 1624197 SMD subclinical menstrual disorders 1 1624198 SMD subcuticular MONOCRYL and DERMABOND 1 1623513 SMD Subgraph Matching Decoding 1 1623514 SMD Subgroup analyses demonstrated effectiveness for child-focused 1 1623515 SMD Subgroup analyses revealed reduced energy diets improved pain 1 1624200 SMD subgroup was thicker than that in the moderate subgroup 1 1624201 SMD subgroup with low or uncertain ACSM adherence 1 1623503 SMD Subject Matter Domain 1 1624212 SMD subjective memory decline facets 1 1624204 SMD subjective methods 1 1624205 SMD subjects compared with non-MetS subjects 1 1624206 SMD subjects had higher MDA levels 1 1624208 SMD subjects with a higher body mass index 1 1623497 SMD Subjects with ACL injury exhibited a significant increase in MTPS 1 1624209 SMD subjects with mild COVID-19 documented higher PT 1 1624210 SMD subjects with rheumatoid arthritis 1 1624207 SMD subjects with T2D had significantly lower tissue compositions of C22:6n-3 1 1624191 SMD subjects, SCH patients exhibited a significantly increased CIMT 1 1624193 SMD submandibular gland duct 1 1624187 SMD submandibular salivary glands 1 1624188 SMD submembrane domains 1 1624189 SMD submucosal diathermy to the inferior turbinates 1 1624190 SMD submucosal gland density 1 1624185 SMD submucosal tissue or deeper 1 1624186 SMD subsequently developed preeclampsia as compared with those did not 1 1624169 SMD subsequently developed preeclampsia than those who did not 1 1624171 SMD substance-based medical device 1 1624172 SMD substantially larger treatment effects of unregistered RCTs 1 1623500 SMD Substrate mediated gene delivery 1 1624173 SMD such as 'severe moving disabilities 1 1624174 SMD sucralose plus dextrose and maltodextrin 1 1624175 SMD sucralose/maltodextrin/dextrose 1 1624176 SMD sucrose monodecanoate 1 1624166 SMD sudden maternal death 1 1623501 SMD Sudomotor dysfunction 1 1624168 SMD suffering from kidney disease 1 1624180 SMD suggested a significant antidepressant effect of oral ketamine 1 1624181 SMD suggested that isoflavones increased lean mass 1 1624183 SMD sukuk market development 1 1624178 SMD sulfate reduced the intraoperative opioid consumption 1 1624179 SMD sulfonamide 1 1624151 SMD sulfonylureas reduced edema the most 1 1624153 SMD sum of maximum diameter 1 1624154 SMD sum of minimum distance 1 1624148 SMD summary index score 1 1624150 SMD superimposed training 1 1624161 SMD superior in postoperative change in demarcation line 1 1624162 SMD superior mediastinal dissection 1 1624163 SMD superior memory function improvement compared to ECT 1 1624164 SMD superior to CWM in reducing the IMT 1 1624165 SMD superiority of laser therapy compared with non-laser treatments 1 1624158 SMD superoxide dismutase (SOD) activity after elimination of publication bias 1 1624159 SMD supplementation also made better clinical response than control group 1 1624160 SMD supplementation also non-significantly associated with an increase in CAT activity 1 1624133 SMD supplementation and a reduction in total cholesterol (TC) concentrations 1 1624134 SMD supplementation and control group on TNF-alpha 1 1624135 SMD supplementation can significantly reduce the levels of circulating CRP 1 1624136 SMD supplementation combined with regular training could enhance the fat oxidation 1 1624126 SMD supplementation compared to controls in both the short term 1 1624127 SMD supplementation compared with controls 1 1624128 SMD supplementation compared with that in the control groups 1 1624129 SMD supplementation could decrease the level of TNF-alpha 1 1624130 SMD supplementation decreased triglyceride (TG) in RA patients 1 1624131 SMD supplementation demonstrated no significant difference in the digit symbol test 1 1624132 SMD supplementation demonstrated significant reductions in ApoB 1 1624145 SMD supplementation did not show statistically significant results on weight loss 1 1624146 SMD supplementation did not significantly affect serum AMH levels 1 1624147 SMD supplementation does not improve endurance exercise performance 1 1624137 SMD supplementation effectively reduces exercise-induced oxidative damage 1 1624138 SMD supplementation for depression in older patients 1 1624139 SMD supplementation had a statistically significant reduction in fasting blood sugar 1 1624140 SMD supplementation had higher levels of high-density lipoprotein 1 1624141 SMD supplementation had lower levels of total cholesterol 1 1624142 SMD supplementation had no effect on ADFI 1 1624144 SMD supplementation had no significant effect on the body weight (BW) 1 1624143 SMD supplementation had no significant effect on WBC 1 1624117 SMD supplementation increased lower-body muscular strength 1 1624116 SMD supplementation increased TAC 1 1624115 SMD supplementation increased the average HDL 1 1624107 SMD supplementation increased weight in juvenile rats 1 1624108 SMD supplementation led to reduced fasting blood glucose 1 1624109 SMD supplementation led to significant reductions in CRP levels 1 1624110 SMD supplementation on ADHD total scores 1 1624111 SMD supplementation on improved HRQOL 1 1624112 SMD supplementation period with lactitol 1 1624113 SMD supplementation reduced FBG level 1 1624114 SMD supplementation reduced tender joint count (TJC) in RA patients 1 1624125 SMD supplementation remarkably decreased the levels of tumor necrosis factor-alpha 1 1624123 SMD supplementation significantly increased acetate 1 1624124 SMD supplementation significantly increased blood n-3 PUFA 1 1624118 SMD supplementation significantly increased testosterone levels 1 1624119 SMD supplementation significantly increased total antioxidant capacity (TAC) level 1 1624120 SMD supplementation significantly lowered alanine transaminase (ALT) levels 1 1624121 SMD supplementation significantly lowered systolic blood pressure 1 1624103 SMD supplementation significantly reduced total cholesterol (TC) 1 1624104 SMD supplementation was associated with significant increases in albumin 1 1624105 SMD supplementation was observed on TNF 1 1624106 SMD supplementation were observed for total distance covered 1 1624533 SMD supplementation with active forms of vitamin D 1 1624532 SMD supplementation, indicating a positive effect 1 1624535 SMD supplementation, respectively, was associated with a lower risk of proteinuria 1 1624527 SMD supplemented meat diet 1 1624534 SMD supplemented Mediterranean diet 1 1624526 SMD supplemented with probiotics 1 1624529 SMD supplementing with vitamin C alone (500-2000 mg/d) 1 1624528 SMD supplements found a non-significant reduction in BMI 1 1624531 SMD supplements, as compared to the placebo group 1 1624530 SMD support compared to other interventions 1 1624539 SMD supported AOT to enhance dynamic balance 1 1624540 SMD surface (dmfs) scores 1 1624514 SMD surface mounted device technology 1 1624513 SMD surface mounted electronic device 1 1624515 SMD surface mounted technology 1 1624511 SMD surface-diameter 1 1624510 SMD surface-mediated gene delivery 1 1623504 SMD Surfactant miscible-displacement 1 1624519 SMD surgeon-maintained database 1 1624521 SMD surgery compared to preoperative levels in children with refractory glaucoma 1 1624520 SMD surgery did not show improvement at 0-6 months 1 1624522 SMD survivors as compared to nonsurvivors 1 1623505 SMD Survivors had significantly lower mean age than non-survivors 1 1624525 SMD susceptible to MD 1 1624524 SMD suspected main diagnoses 1 1624517 SMD suspected of Meningococcal Disease 1 1624516 SMD suspension magnetic damper 1 1624518 SMD sustained decrease in the NAA/mI of PC 1 1624494 SMD sustained for up to three months for PTSD severity 1 1624496 SMD symptom and psychological domains were the most affected 1 1624495 SMD symptom and sign scores 1 1624498 SMD symptom burden 1 1624497 SMD symptom improvements in the probiotic group compared to placebos 1 1623487 SMD Symptom Index 1 1624500 SMD symptomatic major depression 1 1624499 SMD symptoms and sleep quality 1 1624493 SMD symptoms are alleviated post-LLLT in people with AR 1 1624492 SMD symptoms assessed with MADRS scores 1 1624509 SMD symptoms at end of treatment 1 1624502 SMD symptoms based on YMRS change scores 1 1624504 SMD symptoms compared to individuals with autism 1 1624503 SMD symptoms compared to the placebo group 1 1624506 SMD symptoms compared with control 1 1624505 SMD symptoms comprised rhinorrhea 1 1624508 SMD symptoms did not 1 1624501 SMD symptoms in individuals with and without depression 1 1624507 SMD symptoms in PD patients 1 1624481 SMD symptoms of male students 1 1624473 SMD symptoms remained significant after excluding one outlying RCT 1 1624475 SMD symptoms, digital Cognitive Behavioral Therapy (CBT) may be more effective 1 1624478 SMD symptoms, no significant beneficial effects were conferred 1 1624477 SMD symptoms, with higher Hoehn and Yahr stage 1 1624480 SMD synbiotics compared to the control group 1 1624489 SMD syndrome (MetS) 1 1624491 SMD syndrome in comparison to those on placebo 1 1624490 SMD syndrome increased adiponectin levels when compared to those on placebo 1 1624484 SMD syndrome myelodysplastic 1 1624483 SMD syndrome score 1 1624485 SMD syndrome, and prediabetes 1 1624487 SMD synthetic medical data 1 1624486 SMD system interventions were achieved in door-to-needle (DTN) time 1 1624488 SMD system mode-dependent 1 1624470 SMD system was associated with significantly less intraoperative blood loss 1 1623481 SMD Systematic mesopancreas dissection 1 1624469 SMD systematic review findings and interview data about taping 1 1624466 SMD systemic metabolic dysfunction 1 1624465 SMD systemic vascular resistance index (SVRI) 1 1624468 SMD thyroid-stimulating hormone (TSH) 1 1624467 SMD volleyball-specific outcomes, including attack and serve accuracy 1